EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 14

Jujube Ziziphus jujuba Mill.

Also called: da zao, Fructus Jujubae, Zizyphus jujuba (variant spelling)

Jujube is a shrub or tree native to northern and eastern China and Korea, long used as a fruit and remedy. The dried fruit (da zao) is a traditional Chinese medicine ingredient; seed of a spiny variety (suan zao ren) is a separate ingredient.

Category
Botanical
Part used
Fruit (fresh or dried; also syrups and extracts in trials)
Strongest evidence
C Limited
Native range
Native from northern and eastern China to South Korea (POWO: "N. & E. China to S. Korea")
Reviewed
2026-10-29

Class 2 Moderately studied in people. This entry cites 9 RCTs of jujube alone: sources 3-5 and 9-14, oral fruit, powder, infusion, syrup or extract versus placebo, usual care, diet alone or a drug, 2013-2026, 40 to 196 participants. Source 2 is not counted: randomization is not stated. [3]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied3 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Jujube does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Jujube, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Chronic idiopathic constipationCA 12-week placebo-controlled trial in 37 patients with prolonged transit time reported shorter transit time and milder symptoms with a liquid jujube extract; 16 of 19 placebo patients dropped out because of severe constipation. [2]
Functional constipation in childrenCA double-blind trial in children aged 2-10 (62 completed 3 months) found better response scores, fewer soiling episodes and less pain with jujube syrup than with polyethylene glycol. [3]
Blood glucose and lipids in type 2 diabetesCIn a 12-week trial in 48 adults with type 2 diabetes, 30 g/day dried jujube lowered fasting glucose, triglycerides, total and LDL cholesterol compared with control. [4]
Metabolic syndrome measuresCAn 8-week trial (30 g/day jujube powder) found no change in fasting glucose, LDL cholesterol or blood pressure, but improved waist size, triglycerides and HDL; authors noted blinding weaknesses. [5]

Main constituents: Vitamin C, phenolics, flavonoids, triterpenic acids and polysaccharides [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • 30 g/day dried jujube for 12 weeks (type 2 diabetes trial). [4]
  • 30 g/day dried jujube powder for 8 weeks, half at 10 a.m. and half at 4 p.m. (metabolic syndrome trial). [5]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    3 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • In a 3-month pediatric trial, no adverse events or liver or kidney injury were reported with jujube syrup; the authors said further studies are needed to find potential side effects. [3]
Quality

Identity, quality and standardization

  • Health Canada lists jujube fruit (da zao, Ziziphus jujuba) and the seed of Ziziphus jujuba var. spinosa (suan zao ren) as separate ingredients. [7]
Regulation

Regulatory status

  • US: FDA states that, by law, it does not approve dietary supplements before they are marketed; firms are responsible for the safety and labeling of their products. [8]
  • Canada: Ziziphus jujuba fruit (da zao) is listed in Health Canada's Traditional Chinese Medicine Ingredients monograph (May 29, 2026). [7]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Triterpenic acids Triterpenoids [P3]
  • Polysaccharides Polysaccharides [P3]
  • Phenolics and flavonoids Phenolic compounds and flavonoids [P3]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 3 entries naming jujube or Ziziphus/Zizyphus jujuba (earliest NDI 877 submitted 2015-07-31; most recent NDI 1318 submitted 2023-12-14, an unripe jujube fruit extract). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC classification of jujube (Ziziphus jujuba fruit) was found in the IARC Monographs list of classifications (Volumes 1–142, list updated 2026-07-23; checked 2026-10-29). [P2]
  • No NTP technical report (2-year study) on jujube (Ziziphus jujuba fruit) was found in NTP's list of technical reports (checked 2026-10-29). [P7]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) unless FDA grants an exemption petition under 111.75(a)(1)(ii) [P4]
  • Identity of plant part and variety (fruit versus seed of Ziziphus jujuba var. spinosa) — Health Canada lists jujube fruit (da zao) and spiny-jujube seed (suan zao ren) as distinct ingredients [P5]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29 [P6]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  3. Gao QH, Wu CS, Wang M. The jujube (Ziziphus jujuba Mill.) fruit: a review of current knowledge of fruit composition and health benefits. J Agric Food Chem 2013;61(14):3351-63 (PMID 23480594), 2013-04-10. pubmed.ncbi.nlm.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  5. Health Canada, NNHPD. Traditional Chinese Medicine Ingredients monograph (date May 29, 2026), 2026-05-29. webprod.hc-sc.gc.ca
  6. GBIF species API: IUCN Red List category for Ziziphus jujuba Mill., 2026-10-29. api.gbif.org
  7. National Toxicology Program. Technical Reports (list of TR studies; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
Sources

Sources

  1. Gao QH, Wu CS, Wang M. The jujube (Ziziphus jujuba Mill.) fruit: a review of current knowledge of fruit composition and health benefits. J Agric Food Chem 2013;61(14):3351-63 (PMID 23480594), 2013-04-10. pubmed.ncbi.nlm.nih.gov
  2. Naftali T, et al. Ziziphus jujuba extract for the treatment of chronic idiopathic constipation: a controlled clinical trial. Digestion 2008;78(4):224-8 (PMID 19142004), 2008. pubmed.ncbi.nlm.nih.gov
  3. Keihanian F, et al. Comparison of Ziziphus jujube Mill. syrup versus polyethylene glycol in children with functional constipation: a randomized clinical trial. Sci Rep 2025;15(1):1674 (PMID 39799261), 2025-01-11. pubmed.ncbi.nlm.nih.gov
  4. Farhadnejad H, et al. Effect of Ziziphus jujube on cardiometabolic factors and systemic inflammation in type 2 diabetic patients: a randomized controlled trial. Clin Nutr ESPEN 2022;49:53-60 (PMID 35623863), 2022-06. pubmed.ncbi.nlm.nih.gov
  5. Parastouei K, et al. The effects of jujube (Ziziphus jujube) on metabolic and mental health outcomes in patients with metabolic syndrome: a randomized controlled trial. Complement Ther Med 2024;82:103041 (PMID 38648942), 2024-06. pubmed.ncbi.nlm.nih.gov
  6. Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Ziziphus jujuba Mill. (accessed 2026-10-29; native range: "N. & E. China to S. Korea"), 2026-10-29. powo.science.kew.org
  7. Health Canada, NNHPD. Traditional Chinese Medicine Ingredients monograph (date May 29, 2026), 2026-05-29. webprod.hc-sc.gc.ca
  8. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  9. Sabzghabaee AM, et al. Effect of Zizyphus jujuba fruits on dyslipidemia in obese adolescents: a triple-masked randomized controlled clinical trial. Med Arch 2013;67(3):156-9 (PMID 23848030), 2013. pubmed.ncbi.nlm.nih.gov
  10. Kelishadi R, et al. A randomized controlled trial on the effects of jujube fruit on the concentrations of some toxic trace elements in human milk. J Res Med Sci 2016;21:108 (PMID 28250785), 2016-11-07. pubmed.ncbi.nlm.nih.gov
  11. Yazdanpanah Z, et al. Effect of Ziziphus jujube fruit infusion on lipid profiles, glycaemic index and antioxidant status in type 2 diabetic patients: a randomized controlled clinical trial. Phytother Res 2017;31(5):755-762 (PMID 28271568), 2017-03-07. pubmed.ncbi.nlm.nih.gov
  12. Irannejad Niri Z, et al. The effect of dried Ziziphus vulgaris on glycemic control, lipid profile, apo-proteins and hs-CRP in patients with type 2 diabetes mellitus: a randomized controlled clinical trial. J Food Biochem 2021;45(3):e13193 (PMID 32227501), 2020-03-30. pubmed.ncbi.nlm.nih.gov
  13. Mashhadi F, et al. Effects of Ziziphus jujuba, metformin, and myoinositol on pregnancy rates and metabolic parameters in infertile women with PCOS: a randomized controlled trial. J Ovarian Res 2026;19(1):51 (PMID 41618368), 2026-01-30. pubmed.ncbi.nlm.nih.gov
  14. Borzooei R, et al. Ziziphus jujube fruit supplementation improves liver enzymes, lipid profile, and hepatic steatosis but not fasting blood glucose in patients with NAFLD: a randomized controlled trial. Food Sci Nutr 2026;14(8):e72228 (PMID 42577773), 2026-08-10. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.